ArticleScientific reports2026
Serogroups, antibiotic resistance profiles and virulence factors of non-O157 Shiga-toxin producing Escherichia coli from ovine and caprine.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Non-O157 shiga toxin-producing Escherichia coli (STEC) in Africa: a one health systematic review and meta-analysis of prevalence, antimicrobial resistance, and clinical outcomes.Scientific reports · 2026Pooled it
- Virulence Traits and Drug Resistance of STEC Isolated from Layer Poultry andMicroorganisms · 2026Article
- Genotypic Profiling of Virulence and Antibiotic Resistance Genes ofInternational journal of microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Shiga toxin-producing Escherichia coli (STEC) are important zoonotic pathogens linked to foodborne illnesses and outbreaks globally. However, little is known about their prevalence and resistance profiles in small ruminants and their surrounding environment in South Africa. This study investigated the presence and antimicrobial resistance of STEC in small ruminants and their environments from 207 analyzed samples, comprising of faecal samples from sheep (n = 114), goats (n = 58, as well as environmental samples, including manure (n = 27) and water (n = 8) collected from goat and sheep kraals. The presence of E. coli and STEC was detected using the uidA and stx gene PCR assays, respectively. This was followed by the disk diffusion method to determine antibiotic susceptibility profiles of STEC isolates. A total of 112 confirmed E. coli isolates were identified by detecting the uidA gene, with the following distribution: 60 (53.5%) isolates originating from sheep, 46 (41.0%) from goats, and 6 (5.3%) from manure, while no isolates were detected from water samples. Out of 112 uidA PCR positive samples, n = 26 were STEC isolates which were all positive for stx1 (100%) gene, while 7.1% also harboured the stx2 gene. Serogroup analysis revealed O128 (23%) as the most common, followed by O26 (11.5%), O121 (7.6%), and O103 (3.8%), with no detection of high-risk serogroups O157, O113 or O145. Antimicrobial susceptibility testing showed high resistance against ampicillin (88.5%), erythromycin (53.8%), streptomycin (23.1%), ceftriaxone (15.3%), meropenem (11.5%) and gentamycin (3.8%). Only 11.5% of STEC isolates exhibited multidrug resistance (MDR). Genotypic profiling revealed blaSHV (92.3%) as the most prevalent resistance gene, followed by aadA (11.5%) and ampC (11.5%). These findings highlight sheep and goats as potential reservoirs of pathogenic and occasionally multidrug-resistant STEC strains, reinforcing the need for integrated surveillance through a One Health framework to mitigate zoonotic risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.